Former Akebia, Merrimack Buddies Face Insider Trading Trial
Two former biostatistician friends at Akebia Therapeutics Inc. and Merrimack Pharmaceuticals Inc. will face securities fraud charges for allegedly cashing in on nonpublic drug trial information, a federal judge in Massachusetts...To view the full article, register now.
Already a subscriber? Click here to view full article